About
Saphena Medical, Inc. is a medical device company that specializes in innovative technologies for endoscopic vessel harvesting (EVH), which is essential for coronary artery bypass graft (CABG) surgery. With over two decades of experience, the company aims to enhance surgical outcomes and streamline the harvesting process. The flagship product, the Venapax system, is a unitary device that performs dissection, ligation, and extraction of veins or radial arteries in a single instrument. This system simplifies the EVH procedure, reduces the learning curve for new users, and lowers disposable costs. The Venapax system has gained recognition and is widely adopted, including through sole-supplier contracts with major healthcare purchasing programs like Premier Inc.’s SURPASS and ASCEND programs. Led by President and CEO Michael J. Glennon, Saphena Medical's team includes professionals with expertise in product development, regulatory affairs, and finance, ensuring ongoing innovation and operational excellence in the medical device market for cardiovascular procedures.
Technologies
Keywords
Company Information
-
Employees 11
-
Founded 2013
-
Annual Revenue $6000000
-
Total Funding $10250106
Location
375 West Street, West Bridgewater, Massachusetts, United States, 02379